Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-03 to 2024-04-15
Current total value of award: $41.65
Description: 8510549876!GUAIFENESIN AND DEX